Synthesis and antiproliferative screening of para-halogenated 4H-chromene-benzene hybrids: crystallographic, and molecular-docking studies

Authors: Helal, Mohamed H; Eldin, Zienab E; Alrashdi, Saad; Moussa, Ziad; Elgammal, Walid E; Halawa, Ahmed H; Elhenawy, Ahmed A; El-Agrody, Ahmed M

Source journal: RSC advances (2026-11-17)

DOI: 10.1039/d6ra08212b

Abstract

A series of novel 4H-chromene-benzene hybrids bearing para-halogen substituents (F, Cl, Br, I) on the phenyl moiety were efficiently synthesized via an ultrasonic-assisted one-pot three-component cyclocondensation reaction. The reaction proceeded in 93-96% yield within 2 minutes under mild conditions. The structures were fully characterized by IR, 1D/2D NMR, mass spectrometry, and single-crystal X-ray diffraction of 4b. The antiproliferative activity of all compounds was evaluated against twelve human cancer cell lines using the MTT assay. Compound 4b (4-Cl) exhibited the most broadly active profile (mean IC(50) = 16.4 microM), while 4c (4-Br) was the least active (mean IC(50) = 29.6 microM). The SAR was found to be cell-line-dependent, with 4a (4-F) showing superior activity against MDA-MB-231, HCT-116, and SW480. Molecular docking against the EGFR kinase domain (PDB: 4HJO) revealed that 4d (4-I) achieved the most favorable binding energy (-6.953 kcal mol(-1)) and the lowest RMSD (1.878 A), though these computational predictions require experimental validation. In silico ADMET profiling predicted high GI absorption and minimal CYP inhibition for 4a-c. Compound 4b emerged as the most promising lead based on its balanced activity and favorable pharmacokinetic profile. The proposed EGFR-mediated mechanism remains hypothetical and warrants experimental confirmation.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.